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The mammalian mitochondrial methionyl-tRNA
transformylase (MTFmt) was partially purified 2,200-fold
from bovine liver mitochondria using column chroma-
tography. The polypeptide responsible for MTFmt activ-
ity was excised from a sodium dodecyl sulfate-polyacryl-
amide gel and the amino acid sequences of several
peptides were determined. The cDNA encoding bovine
MTFmt was obtained and its nucleotide sequence was
determined. The deduced amino acid sequence of the
mature form of MTFmt consists of 357 amino acid resi-
dues. This sequence is about 30% identical to the corre-
sponding Escherichia coli and yeast mitochondrial
MTFs. Kinetic parameters governing the formylation of
various tRNAs were obtained. Bovine MTFmt formylates
its homologous mitochondrial methionyl-tRNA and the
E. coli initiator methionyl-tRNA (Met-tRNAfMet) with es-
sentially equal efficiency. The E. coli elongator methio-
nyl-tRNA (Met-tRNAmMet) was also formylated although
with somewhat less favorable kinetics. These results
suggest that the substrate specificity of MTFmt is not as
rigid as that of the E. coli MTF which clearly discrimi-
nates between the bacterial initiator and elongator Met-
tRNAs. These observations are discussed in terms of the
presence of a single tRNAMet gene in mammalian
mitochondria.
During the initiation of protein biosynthesis the initiator
methionyl-tRNA is bound to the ribosomal P-site. In pro-
karyotes, this step is facilitated by initiation factor 2 (IF-2)1
while in the eukaryotic cytoplasm this step is mediated by
eIF-2. In contrast, all other aminoacyl-tRNAs function as elon-
gator tRNAs and enter the A-site of the ribosome in a complex
with elongation factor Tu (EF-Tu) in prokaryotes or eEF-1 in
the eukaryotic cell cytoplasm (1). In most organisms, the initi-
ator tRNA has distinct features that ensure its selection during
the initiation process and its exclusion from the steps of
polypeptide chain elongation. In prokaryotes and eukaryotic
organelles, such as mitochondria and chloroplasts, the methi-
onine attached to the initiator tRNA undergoes formylation at
its amino group through the action of the enzyme methionyl-
tRNA transformylase (MTF) (2–4). In Escherichia coli, MTF
discriminates strictly between the initiator tRNA and the
tRNAs used for chain elongation by recognizing specific deter-
minants in the initiator tRNA (5). Formylation of methionyl-
tRNA is necessary for the interaction of the tRNA with IF-2.
Formylation also eliminates any significant interaction with
EF-Tu. In the yeasts and plants, the initiator tRNA is not
formylated. However, Met-tRNAiMet is excluded from chain
elongation by the presence of a 29-O-ribosyl phosphate modifi-
cation at position 64 of the initiator tRNA (6).
The translational system in animal mitochondria is thought
to be more closely related to that of prokaryotes than to that of
the eukaryotic cell cytoplasm (7, 8). This idea is based on the
use of fMet-tRNA for initiation, on the antibiotic sensitivity of
the ribosomes, and on the ability of the mammalian mitochon-
drial elongation factors to function on bacterial ribosomes.
However, animal mitochondrial protein synthesis has a num-
ber of unusual features that distinguish it from other transla-
tional systems. In general, mitochondrial tRNAs are shorter
than their prokaryotic or eukaryotic cytoplasmic counterparts
(59–75 nucleotides in length). They display numerous primary
structural differences from “normal” tRNAs. In some cases,
they cannot be folded into the typical cloverleaf secondary
structure and lack one or more of the invariant or semi-invari-
ant residues found in other tRNAs (9). There are genes for 22
tRNAs in the mammalian mitochondrial genome (10). This
number is sufficient to read the altered genetic code found in
this organelle. There is a single tRNA for each amino acid
except for leucine and serine for which two tRNAs are required.
A single gene for tRNAMet is present and no tRNAs appear to be
imported into mammalian mitochondria (11). It is unclear how
a single tRNAMet species can play the dual roles of an initiator
and an elongator tRNA. Translational initiation in mammal
mitochondria requires fMet-tRNA for the IF-2mt-dependent
binding to ribosomes. However, the unformylated form is re-
quired by EF-Tumt for chain elongation (12, 13). Thus, the
single tRNAMet gene must give rise to two species of tRNA
(fMet-tRNA and Met-tRNA). This process requires a mecha-
nism to adjust the ratio of formylated to non-formylated Met-
tRNAs to meet the needs of both initiation and elongation. As
a first step toward the investigation of this process, we report
here the purification, cloning, and characterization of bovine
mitochondrial MTF (MTFmt).
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EXPERIMENTAL PROCEDURES
Materials
Folinic acid and CHAPS were purchased from Sigma. [35S]Methi-
onine (37 TBq/mmol) and [14C]methionine (1.85 GBq/mmol) were ob-
tained from Amersham. DEAE-Sepharose fast flow, Mono S (HR5/5), Hi
Trap Blue, and Hi Trap Heparin columns were purchased from Phar-
macia. An affinity column using an immobilized E. coli tRNA mixture
was prepared as described (14).
Buffers
Buffer TG contains 20 mM Tris-HCl (pH 7.6), 1 mM MgCl2, 0.1 mM
EDTA, 6 mM b-mercaptoethanol, 10% glycerol, 0.1 mM phenymethyl-
sulfonyl fluoride. Buffer PG contains 20 mM potassium phosphate (pH
6.8), 10% glycerol, 1 mM dithiothreitol, 0.1 mM phenymethylsulfonyl
fluoride, 0.5% CHAPS.
Analytical Methods
Protein concentrations were determined by the Bio-Rad protein as-
say kit using bovine serum albumin as a standard. Sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was carried out
according to Laemmli (15).
Preparation of Mitochondrial Methionyl-tRNAMet and E. coli
Methionyl-tRNAsMet
Mitochondrial Met-tRNA synthetase (MetRSmt) was partially puri-
fied from mitochondrial extracts by chromatography on DEAE-Sepha-
rose and ceramic hydroxyapatite (Bio-Rad). E. coli MetRS was partially
purified from E. coli extracts by chromatography on DEAE-Sepharose
and ceramic hydroxyapatite (Bio-Rad). Mitochondrial tRNAMet was pu-
rified by a solid-phase hybridization method using DNA probes comple-
mentary to the 30 bases at the 39-end of the tRNA (16). E. coli tRNAfMet
and tRNAmMet were purified as described (17, 18). Further purification
was carried out on a 6% native polyacrylamide gel if necessary.
Aminoacylation of mitochondrial tRNAMet was carried out in reaction
mixtures (100 ml) containing 100 mM Tris-HCl (pH 8.5), 14 mM
Mg(OAc)2, 20 mM KCl, 2 mM dithiothreitol, 4 mM ATP, 1 mM spermine,
20 mM [35S]methionine (200 GBq/mmol), 2–4 mM tRNAMet, and saturat-
ing amounts of partially purified MetRSmt. The tRNA was extracted
using phenol equilibrated at pH 5.0 and the remaining ATP and me-
thionine were removed on a Hi Trap desalting gel (Pharmacia). Ami-
noacylation of E. coli tRNA was carried out with [35S] or [14C]methi-
onine as described (19) and the Met-tRNAs were purified as described
above.
Purification of Bovine Liver Mitochondrial MTF
The bovine liver mitochondria were prepared as described (20).
About 60 g of mitochondria were resuspended in 240 ml of Buffer TG
containing 0.005 M KCl (TG.005), and disrupted by sonication using five
20-s bursts at 100 watts followed by 40-s cooling periods. The homoge-
nate was subjected to centrifugation at 100,000 3 g for 180 min. The
supernatant fraction (S100) was either processed immediately or frozen
quickly and stored at 270 °C.
Step 1: Chromatography on DEAE-Sepharose—CHAPS was added to
a final concentration of 0.2% (w/v) to all the buffers indicated below. The
S100 (5,700 mg) was applied to a 100-ml DEAE-Sepharose fast flow
column (17.5 3 2.7 cm) equilibrated with Buffer TG.005, at a flow rate
of about 2.0 ml/min. The column was washed by Buffer TG.005 until the
absorbance at 280 nm became less than 0.1 and the proteins bound to
the column were eluted by a 1.0-liter linear gradient of 5–400 mM KCl
in Buffer TG. Fractions (10 ml) were collected at a flow rate of 2.0
ml/min. Fractions containing MTFmt activity were pooled and concen-
trated by ammonium sulfate precipitation (45–60% saturation). The
pellet was then dissolved in Buffer PG and dialyzed against Buffer PG
containing 0.15 M KCl (PG.15) for 6 h with two changes of buffer.
Step 2: Chromatography on Mono S—The sample (1,300 mg) was
applied to a Mono S column (0.5 3 5 cm) equilibrated in Buffer PG.15
at a flow rate of 0.25 ml/min. The column was then washed with Buffer
PG.15 and developed with a 10-ml linear gradient from 0.15 to 0.4 M
KCl in Buffer PG. Fractions (0.25 ml) were collected at the flow rate of
0.25 ml/min. The fractions with MTFmt activity were pooled and diluted
with Buffer PG until the concentration of KCl was less than 0.25 M. The
sample was immediately frozen and stored at 270 °C.
Step 3: Chromatography on Hi Trap Blue—The sample (1.6 mg) was
applied at a flow rate of 0.25 ml/min to a Hi Trap Blue column (1 ml)
equilibrated in Buffer PG containing 0.25 M KCl (PG.25). After washing
with Buffer PG.25, bound proteins were eluted with a 10-ml linear
gradient from 0.25 to 0.75 M KCl in Buffer PG. Fractions (0.25 ml) were
collected at the flow rate of 0.25 ml/min. The fractions with MTFmt
activity were pooled and diluted with Buffer PG to decrease the KCl
concentration to less than 0.10 M. The sample was then frozen quickly
and stored at 270 °C.
Step 4: Chromatography on a Column Carrying Immobilized
tRNA—E. coli tRNA was immobilized on CNBr-activated Sepharose 4B
(Pharmacia). The partially purified sample (0.24 mg) containing MTFmt
activity was applied to the column (0.5 3 2.1 cm) which had been
equilibrated in Buffer PG containing 0.1 M KCl (PG.10). The column
was developed with a linear gradient (0.10 to 0.60 M KCl in Buffer PG).
Fractions (0.1 ml) were collected at the flow rate of 0.1 ml/min. The
fractions showing MTFmt activity were diluted with Buffer PG to reduce
the concentration of KCl to less than 0.25 M and stored at 270 °C.
Step 5: Chromatography on Hi Trap Heparin—The sample (0.13 mg)
was applied to a Hi Trap Heparin column (1 ml) equilibrated with
Buffer PG.25. The column was washed with Buffer PG.25 and devel-
oped with a 10-ml linear gradient from 0.25 to 0.75 M KCl in Buffer PG.
Fractions of 0.25 ml were collected at the flow rate of 0.25 ml/min.
Fractions with MTFmt activity were pooled and dialyzed against buffer
containing 20 mM Tris-HCl (pH 7.6), 10 mM KCl, 5 mM MgCl2, 10%
glycerol, 1 mM dithiothreitol, and 0.5% CHAPS. The sample was divided
into small aliquots, fast-frozen, and stored at 270 °C.
Assays of Bovine MTFmt Activity
The assay of the formylation activity was carried out according to
Ref. 21 with a slight modification as follows. Reaction mixtures (50 ml)
contained 20 mM Tris-HCl (pH 7.6), 10 mM KCl, 5 mM MgCl2, 0.1 mg/ml
bovine serum albumin, 0.5% (w/v) CHAPS, 1 mM dithiothreitol, 1 mM E.
coli [14C]Met-tRNAfMet, 0.3 mM N10-formyltetrahydrofolate, and the
indicated amounts of MTFmt.
Determination of the Amino Acid Sequence of MTFmt
The partially purified sample containing MTFmt was subjected to
SDS-PAGE and blotted onto a siliconized glass-fiber membrane (22).
The band believed to be MTFmt (based on the correlation between the
intensity of this band and the activity of MTFmt) was excised. The
amino-terminal sequence was obtained on an Applied Biosystems 477A/
120A protein sequencer. The sequences of internal peptides were ob-
tained according to Cleveland et al. (23) with modifications indicated in
Ref. 24.
Screening of cDNA Libraries and DNA Sequencing
Approximately 1 3 106 plaques from a bovine heart cDNA library
(Uni-ZAPTM XR, Stratagene) were screened by hybridization with a
putative human MTFmt cDNA probe labeled by random priming (25).
Hybridizations were carried out at 65 °C with 6 3 SSC buffer contain-
ing 20 mM NaH2PO4 and 0.4% (w/v) SDS (26). Positive plaques were
isolated and the pBluescript SK(2) plasmid clones were excised in vivo
TABLE I
Purification of mitochondrial MTFmt from bovine liver
Purification step Protein Total units Specific activitya Total recovery Purification
3103 mg 3103 unit/mg % -fold
Mitochondrial extractb (S-100) 5,700 1,100 0.19 100 1
DEAE-Sepharose 1,300 420 0.32 38 1.7
Mono S 1.6 27 17 2.5 89
Hi Trap Blue 0.24 7.5 31 0.068 160
Affinity column (tRNAE. coli
mix -Sepharose) 0.13 7.0 54 0.064 280
Hi Trap Heparin 0.010 4.2 420 0.038 2,200
a Specific activity; 1 unit of the enzyme is the capacity of formylating 1 pmol of E. coli Met-tRNAfMet in 1 min at 30 °C.
b From 63 g (wet weight) of bovine mitoplast.
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according to the manufacturer’s instructions (Stratagene). Plasmid
DNA was subjected to autosequencing using a HITACHI SQ-5500
sequencer (27).
RESULTS AND DISCUSSION
Purification of MTFmt—The initiation of protein synthesis in
mitochondria requires the use of the formylated initiator tRNA
(fMet-tRNA). Hence, this organelle must possess a factor equiv-
alent to the bacterial methionyl-tRNA transformylase. When
extracts of bovine mitochondria were tested for a factor that
could carry out the formylation of E. coli Met-tRNAfMet, a small
amount of activity could be detected. The partial purification of
this activity (MTFmt) was carried out by successive column
chromatography as described under “Experimental Proce-
dures” (Table I).
The purification scheme resulted in a 2,200-fold purification
of MTFmt with an overall yield of about 0.04%. Throughout the
purification scheme, the recovery of MTFmt was significantly
improved by the addition of the detergent CHAPS to all of the
buffers used. This observation suggests that there are hydro-
phobic patches on MTFmt that lead to the absorption of this
factor on the matrices of various resins or that reduce its
solubility resulting in substantial losses of activity. Analysis of
the partially purified preparation of MTFmt on SDS-PAGE
(Fig. 1B) showed the presence of three major polypeptide
bands. The band with a molecular mass of about 40,000 daltons
was tentatively identified as MTFmt. The intensity of this band
correlated with the amount of MTFmt activity observed. In
addition, the transformylase would be expected to be about this
size. This polypeptide represented about 25% of the protein in
the partially purified sample. About 2.5 mg of MTFmt were
obtained from 2 kg of bovine liver.
Amino Acid Sequence Determination of Peptides Derived
from MTFmt and cDNA Cloning—In order to obtain cDNA
clones of MTFmt, partial peptide sequences were determined.
MTFmt was first subjected to NH2-terminal Edman degrada-
tion. Second, for the determination of internal amino acid se-
quences, peptides resulting from digestion with endoproteinase
V8 were purified by polyacrylamide gel electrophoresis and
subjected to Edman degradation. Three peptide sequences
were obtained (Table II).
These sequences were then used to search the data bases.
The partial sequence of one human cDNA (GenBank number
108908) included the sequence EVVTVPSPSP found as an in-
ternal peptide in bovine MTFmt. The nucleotide sequence of
this cDNA contained a 400-bp region which was homologous to
E. coli MTF. This cDNA clone was, thus, predicted to encode a
portion of human MTFmt. Probes prepared from this putative
human MTFmt cDNA hybridized with the E. coli MTF gene
(data not shown). A bovine heart Uni-ZAPTMXR cDNA library
was screened using the human cDNA clone as a probe. Five
positive plaques were isolated among 1 3 106 plaques, and theFIG. 1. Purification of bovine MTFmt. A, elution profile of MTFmt
on Hi Trap Heparin. The column was developed as described under
“Experimental Procedures.” Samples (10 ml) were assayed for MTFmt
activity (open circles). Absorbance at 280 nm (solid line) was monitored
using the scale of 0 to 0.1. The column was developed with the linear
salt gradient (dashed line). B, SDS-PAGE analysis of MTFmt. The
sample (2 mg) purified from Hi Trap Heparin was analyzed on SDS-
PAGE analysis. The molecular weight markers were phosphorylase b
(105,000), bovine serum albumin (70,800), ovalbumin (43,600), and
carbonic anhydrase (28,250). The arrow indicates the band that was
excised for sequence analysis.
FIG. 2. Nucleotide and deduced amino acid sequences of bovine liver MTFmt. The amino acid numbered 11 corresponds to the first
residue of the mature form of MTFmt. The putative polyadenylation signals are underlined, and (a)n denotes the poly(a) tail.
TABLE II
Sequences of peptide fragments derived from bovine liver MTFmt
Peptide Position
1 5 NH2-ASPPWED 1–7
2 5 EVVTVPSPSP 53–62
3 5 ETVPVPPKST 162–171
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plasmids carrying the cDNA inserts of interest were excised in
vivo. The largest clone characterized carried a 1355-bp insert
(Fig. 2). Sequence analysis indicated that this clone contained
the entire coding region for the mature form of MTFmt (1071
bp) and a portion of a putative mitochondrial import signal (45
bp). The 39-untranslated region was 220 bp in length and
contained a conventional polyadenylation signal (AAUAAA) 17
nucleotides upstream of the poly(A) tail (Fig. 2) (28).
Characterization of the Sequence of Bovine MTFmt—The ma-
ture form of MTFmt is 357 amino acids in length and has a
molecular weight of 40,017. This value is consistent with the
molecular weight of the band identified as MFTmt on SDS-
PAGE. The amino acid sequence of MTFmt is about 30% iden-
tical to the corresponding prokaryotic factors (Fig. 3A) (29–33).
It is interesting to note that the sequence of bovine MFTmt is
also only 28% identical to that of yeast MTFmt (34) (Table III).
It should be noted that, while the NH2-terminal amino acid
sequence obtained by peptide sequencing was ASPGWED, the
cDNA sequence obtained gave the sequence ASPPWED when
translated into the amino acid sequence. This apparent dis-
crepancy could arise if there is more than one copy of MTFmt
gene in the bovine nuclear genome with slightly different
sequences.
The crystal structure of E. coli MTF has recently been de-
termined (35). Analysis of this structure indicates that MTF
contains two domains, NH2-terminal and COOH-terminal do-
mains. NH2-terminal domain carries the tetrahydrofolate
(THF)-binding site in which the THF binding motif (SLLP
motif) is contained, as well as a Rossman fold (35). The longest
stretch of conserved residues among the MTFs from various
sources is located in the THF-binding site proposed for E. coli
MTF (35) (Fig. 3). The COOH-terminal domain provides a
positively charged surface oriented toward the active center of
the enzyme and is, presumably, involved in positioning the
Met-tRNA substrate for the formylation reaction. The THF
binding motif is present as SCLP in bovine MTFmt, and the Phe
at position 14, which is assumed to be responsible for the
interaction of E. coli MTF with the 39-end of the Met-tRNA (35),
is also conserved in the bovine mitochondrial counterpart (Phe-
29) (Fig. 3). The COOH-terminal domain of E. coli MTF is
FIG. 3. Multiple sequence alignment of MTF polypeptides from various sources. The sequences are those of the enzymes from E. coli,
Thermus thermophilus (T. thermoph), Hemophilus influenzae (H. influenz), Mycoplasma genitalium (M. genitali), Bacillus subtilis (B. subtilis),
Saccharomyces cerevisiae mitochondria (Yeast (mt)), and bovine liver mitochondria (Bovine(mt)). Multiple sequence alignment of MTF polypeptides
was performed with the CLUSTAL V program. The positions strictly conserved in the seven compared sequences are marked with an asterisk below
the sequence. Positions with conservative replacements are designated by a dot. The THF-binding site containing the THF binding motif (SLLP
motif) and the residues thought to interact with the 39-end of tRNAMet in the case of E. coli MTF are conserved (gray box) (19, 35). The secondary
structure of E. coli MTF is designated with red (a-helix) and blue (b-strand) lines above the sequence (35). The region that is speculated to correlate
with the unique substrate specificity of bovine MTFmt is shown with bold letters. This region corresponds to the insertion sequence in the Rossman
fold which is usually variable in length in the class I aminoacyl-tRNA synthetases (41).
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characterized by an oligonucleotide binding fold termed the OB
fold. The OB fold is formed by two orthogonal sheets consisting
of five antiparallel strands folded into a b-barrel surrounded by
a-helices (35). Secondary structure predictions using the Chou-
Fasman or Robson methods (36, 37) have not able been to
clearly identify a similar structure in MTFmt. The Lys at posi-
tion 207 in the linker region between the two domains of E. coli
MTF is thought to be involved in the interaction with the
39-end of the tRNA (19). This residue (Lys-214) has been con-
served in the spacer region between the domains of MTFmt
(Fig. 3).
Characterization of Substrate Specificity of MTFmt—The ini-
tiation of translation in most prokaryotic organisms requires
the formylation of the initiator Met-tRNA by MTF. In E. coli,
the formyl group is a positive determinant for the specific
interaction of IF-2 with the initiator tRNA. It also serves as a
negative determinant that nearly eliminates the binding of
EF-Tu to the initiator tRNA (5). Bacterial MTF will not formyl-
ate the Met-tRNAmMet species used for chain elongation. The
strict substrate specificity of E. coli MTF is essential to ensure
the accuracy and the efficiency of the initiation process. In
contrast to all other systems, animal mitochondria do not con-
tain two distinct methionyl-tRNA species that are used exclu-
sively for the initiation or elongation phases of protein synthe-
sis. Mammalian mitochondria have a single tRNAMet gene
which is encoded in the organelle genome (10). There is no
evidence that cytoplasmic tRNAs are imported into animal
mitochondria (11). Thus, the single tRNAMet gene must, in
some unknown manner, give rise to both an initiator tRNA
(fMet-tRNA) and an elongator tRNA (Met-tRNA) (35, 19).
The unique presence of a single Met-tRNA species in mam-
malian mitochondria made it of considerable interest to ad-
dress the substrate specificity of MTFmt. The kinetic parame-
ters governing the formylation of three native tRNA molecules,
bovine mitochondrial Met-tRNA, E. coli Met-tRNAfMet, and E.
coli Met-tRNAmMet, were measured (Table IV). The results of
these experiments indicated that MTFmt is clearly able to use
E. coli Met-tRNAfMet with a Vmax that is about 3-fold higher
than that observed with the mitochondrial Met-tRNAMet. The
Km observed with the E. coli initiator tRNA is a little over
3-fold higher than with the mitochondrial tRNAMet. The net
result is that the relative Vmax/Km for these two tRNAs are
essentially the same. Surprisingly, MTFmt was also able to
formylate the E. coli elongator Met-tRNAmMet. This tRNA is
never a substrate for formylation by the homologous E. coli
MTF (38). The Km value observed with Met-tRNA
mMet is es-
sentially the same as that observed for E. coli Met-tRNAfMet
while the Vmax is about 3-fold lower than that observed with
the mitochondrial Met-tRNA. MTFmt clearly does not discrim-
inate between the bacterial initiator and elongator Met-tRNAs.
This observation is compatible with the fact that there is a
single Met-tRNA species in mammalian mitochondria.
E. coli MTF is known to have some affinity for many different
tRNAs that is mediated through an interaction between the
39-end of the acceptor stem of the tRNA and regions surround-
ing Lys-207 in MTF (19) (Fig. 4). However, only Met-tRNAfMet
is a substrate for the actual formylation process. It has been
speculated that the formylation reaction is triggered by the
melting of the acceptor stem of Met-tRNAfMet which is facili-
tated in the initiator tRNA by the unstable acceptor stem found
in this tRNA (19, 39). Several residues in MTF are thought to
be involved in this melting process, such as basic residues in
the loop I, and Phe-14 (35, 40) (Fig. 4). Phe-14 corresponds to
Phe-29 in MTFmt, but Arg-42 in the loop I could not be identi-
fied clearly in MTFmt. A comparison of the sequences of pro-
karyotic MTF and yeast MTFmt with the sequence of bovine
MTFmt does not provide a clear rationale for the structural
basis for the Met-tRNA specificities of these enzymes. How-
ever, it should be noted that the region termed the “insertion
sequence” in the Rossman fold, which is usually variable in
FIG. 4. Schematic drawing of tertiary structure of MTFs from
prokaryotes (A) and bovine mitochondria (putative) (B). The
region around the insertion sequence in the Rossman fold of MTFmt is
shorter than that of prokaryotic MTFs. The important elements for
tRNA recognition in MTFmt might be located closer compared with
those of prokaryotic MTF (Phe-14, basic residues in the loop I, and
Lys-207 in E. coli MTF; see text). This topological difference might
allow MTFmt to formylate Met-tRNA with the rigid acceptor stem.
TABLE IV








E. coli (f) 2.4 0.091 0.83
E. coli (m) 0.28 0.095 0.091
Bovine mitochondria 0.8 0.025 1
a Relative Vmax/Km is the ratio of Vmax/Km of mitochondorial Met-
tRNA to Vmax/Km of each Met-tRNA.
TABLE III
Identity of the known MTF amino acid sequences from various organisms
Sequence comparisons were done with the Maximum Matching program in GENETYX version 7.0. The designations used are as follows: E. coli,
Thermus thermophilus (T. thermophilus), Haemophilus influenzae (H. influenzae), Mycoplasma genitalium (M. genitalium), Bacillus subtilis (B.
subtilis), Saccharomyces cerevisiae mitochondria (Yeast (mt)), and bovine liver mitochondria (Bovine (mt)).
E. coli T. thermophilus H. influenzae M. genitalium B. subtilis Yeast (mt) Bovine (mt)
% % % % % % %
E. coli 100
T. thermophilus 44 100
H. influenzae 65 40 100
M. genitalium 26 23 29 100
B. subtilis 43 39 40 32 100
Yeast (mt) 29 29 29 24 27 100
Bovine (mt) 29 28 29 24 28 28 100
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length in class I aminoacyl-tRNA synthetases (41), is shorter in
the case of bovine MTFmt than in prokaryotic MTF (Figs. 3 and
4). The difference in this distance would be expected to place a
number of residues in somewhat different positions in MTFmt.
This difference might permit the mitochondrial factor to form
the transition state with the elongator Met-tRNA easily. Hence
it might be able to formylate the elongator Met-tRNA without
the necessity for melting the acceptor stem. Further experi-
ments will be designed to evaluate this idea.
How the single tRNAMet gene gives rise to both an initiator
and an elongator tRNAMet species still remains unknown at
this time. One possibility is that the formylation of Met-tRNA
converts it from the elongator to the initiator tRNA since
formylation increases its affinity for IF-2mt and diminishes its
ability to form a complex with EF-Tumt. The ratio of formylated
to the non-formylated Met-tRNA might be regulated by a com-
petition between MTFmt and EF-Tumt for Met-RNA. The puri-
fication and characterization of MTFmt as described here will
allow us to investigate this issue by using purified IF-2mt and
EF-Tumt. Alternatively, the activity of MTFmt might be regu-
lated by an unknown mechanism in vivo in conjunction with
the initiation of mitochondrial protein synthesis. An investiga-
tion of this possibility must await the development of a better
understanding of the initiation of mitochondrial protein
synthesis.
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